Rating Rationale
November 19, 2019 | Mumbai
Santhigiri Ayurveda Siddha Vaidyasala
Rating Reaffirmed
 
Rating Action
Total Bank Loan Facilities Rated Rs.9 Crore
Long Term Rating CRISIL BB-/Stable (Reaffirmed)
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISIL has reaffirmed its 'CRISIL BB-/Stable' rating on the bank facilities of Santhigiri Ayurveda Siddha Vaidyasala (SASV).
 
The ratings reflect SASV's established distribution network, benefits derived from being part of the Santhigiri Ashram, and healthy debt protection metrics. These rating strengths are partially offset by the modest scale of operations, revenue concentration in Kerala, subdued capital structure, and moderate working capital requirements.

Analytical Approach

Unsecured loans from promoters (of Rs. 2.59 crores as on March 31, 2019) have been treated as neither debt nor equity, as they will remain in the business over the medium term.

Key Rating Drivers & Detailed Description
Strengths
* Established distribution network: Association with the Santhigiri Asharam has helped the society build a vast distribution network, comprising its own 90 centres and nearly 600 agents. This has helped assure steady demand and led to higher operating income of Rs 47.82 crore in fiscal 2019.
 
* Healthy debt protection metrics: Debt protection indicators are healthy, marked by interest coverage and net cash accrual to adjusted debt (NCATD) ratios of 7.15 times and 0.82 time, respectively, in fiscal 2019.  Sustained operating margin and thus, net cash accruals shall continue to support the debt protection metrics over the medium term.
 
Weaknesses
* Modest scale of operations: Intense competition from other local players offering ayurvedic formulations, will continue to restrict scalability of operations. Hence, revenue was modest at Rs 47.82 crore in fiscal 2019.
 
* Limited geographical diversity: The society derives almost 80% of its revenue from Kerala, and thus, faces high geographical concentration risk. Topline growth highly remains vulnerable to policies of the state government, and SASV's customers.
 
* Subdued capital structure: As on March 31, 2019, the gearing and total outside liabilities to adjusted networth (TOLANW) ratios were high at 1.91 times and 4.0 times (after treating unsecured loans as NDNE), respectively. This was mainly on account of decrease in networth to Rs 3.8 crore as on March 31, 2019 (Rs 6.8 crore, a year ago), due to withdrawal of capital by the members. Infusion of capital by the members shall remain a key monitorable factor with respect to improvement in the capital structure over the medium term.
 
* Moderate working capital requirement: Operations are moderately working capital intensive, as reflected in gross current assets of 94 days as on March 31, 2019, primarily due to inventory of 65 days, debtor days being low at 19 days. The society holds larger stock of inventory, and hence the inventory levels appears high.  CRISIL believes that the working capital requirements is expected to be on similar lines over the medium term.

Liquidity: Stretched
Liquidity is stretched, mainly due to high bank limit utilisation, which averaged 99% over the 12 months through October 2019. Net cash accrual of Rs 6-7 crore, expected each in fiscals 2020 and 2021, could be used to cover the incremental working capital requirement, in the absence of any maturing debt. Enhancement in existing bank limit remains a key monitorable. Cash and cash equivalents of Rs 0.59 crore, and unsecured loans of Rs 2.17 crore, extended by promoters, as on March 31, 2019, partly support liquidity.
Outlook: Stable

CRISIL believes SASV will continue to benefit from its established position in the ayurvedic formulations market.

Rating sensitivity factors
Upward Factors
* Sustained revenue growth and sustenance of operating margin, leading to higher cash accrual
* Reduction in bank limit utilisation (below 90%) with enhancement in existing bank lines or improved working capital cycle, thus improving liquidity

Downward Factors
* Decline in revenue and operating margin leading to cash accruals
* Substantial increase in working capital requirement (GCA more than 300 days), weakening liquidity and financial risk profile.

About the Society

SASV was established in 1978, by Navajyothisree Karunakara Guru, founder of Santhigiri Ashram. SASV manufactures ayurvedic medicines at its facility in Trivandrum (Kerala). It also provides ayurvedic treatments.

Key Financial Indicators
Particulars Unit 2019* 2018
Revenue Rs. Cr. 104.41 126.45
Profit After Tax (PAT) Rs. Cr. 0.13 0.55
PAT Margins % 0.1 0.4
Adjusted Debt/Adjusted Networth Times 0.86 1.26
Interest coverage Times 1.37 1.53
*Provisional

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments. The CRISIL complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.
Annexure - Details of Instrument(s)
ISIN Name of Instrument Date of Allotment Coupon
Rate (%)
Maturity Date Issue
Size
(Rs.Cr)
Rating Assigned  with Outlook
NA Cash Credit* NA NA NA 7.2 CRISIL BB-/Stable
NA Long Term Loan NA NA Dec-2019 1 CRISIL BB-/Stable
NA Proposed Long Term Bank Loan Facility NA NA NA 0.8 CRISIL BB-/Stable
*Reduced to Rs 7.2 crore in fiscal 2019
Annexure - Rating History for last 3 Years
  Current 2019 (History) 2018  2017  2016  Start of 2016
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund-based Bank Facilities  LT/ST  9.00  CRISIL BB-/Stable  23-01-19  CRISIL BB-/Stable      22-11-17  CRISIL BB-/Stable  23-08-16  CRISIL BB-/Stable  CRISIL BB-/Stable 
Non Fund-based Bank Facilities  LT/ST    --  23-01-19  CRISIL A4+      22-11-17  CRISIL A4+  23-08-16  CRISIL A4+  CRISIL A4+ 
All amounts are in Rs.Cr.
 
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Cash Credit* 7.2 CRISIL BB-/Stable Bank Guarantee .12 CRISIL A4+
Long Term Loan 1 CRISIL BB-/Stable Cash Credit 7.5 CRISIL BB-/Stable
Proposed Long Term Bank Loan Facility .8 CRISIL BB-/Stable Long Term Loan 1 CRISIL BB-/Stable
-- 0 -- Proposed Long Term Bank Loan Facility .38 CRISIL BB-/Stable
Total 9 -- Total 9 --
*Reduced to Rs 7.2 crore in fiscal 2019
Links to related criteria
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating criteria for manufaturing and service sector companies
Rating Criteria for the Pharmaceutical Industry
CRISILs Criteria for rating short term debt

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Rahul Guha
Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8320
rahul.guha@crisil.com


Ankita Gupta
Associate Director - CRISIL Ratings
CRISIL Limited
D:+91 22 4097 8104
ankita.gupta@crisil.com


Swapnali Mane
Rating Analyst - CRISIL Ratings
CRISIL Limited
D:+91 22 3342 1856
Swapnali.Mane@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL